William Shakespeare

Insider Reports History

Entity
Individual
Location
245 Main Street, 2 Nd Floor, Cambridge, MA
Signature
/s/ Bradford Dahms - Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Shakespeare:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Theseus Pharmaceuticals, Inc. President of Research and Development Common Stock 639K $1.95M $3.05 Nov 6, 2023 Direct
Theseus Pharmaceuticals, Inc. President of Research and Development Restricted Stock Units 21.3K $64.8K $3.05 Mar 1, 2023 Direct
Theseus Pharmaceuticals, Inc. President of Research and Development Stock Option (right to buy) 93.3K Nov 6, 2023 Direct

Insider Reports Filed by William Shakespeare

Symbol Company Period Transactions Value $ Form Type Date Filed Role
THRX Theseus Pharmaceuticals, Inc. Nov 6, 2023 2 $80.3K 4 Nov 7, 2023 President of Research and Development
THRX Theseus Pharmaceuticals, Inc. Mar 1, 2023 1 $0 4 Mar 2, 2023 President of Research and Development
THRX Theseus Pharmaceuticals, Inc. Feb 17, 2023 1 $0 4 Feb 21, 2023 President of Research and Development
THRX Theseus Pharmaceuticals, Inc. Feb 18, 2022 1 $0 4 Feb 23, 2022 President of Research and Development
THRX Theseus Pharmaceuticals, Inc. Oct 12, 2021 1 $10K 4 Oct 14, 2021 President of Research and Development
THRX Theseus Pharmaceuticals, Inc. Oct 6, 2021 0 $0 3 Oct 6, 2021 President of Research and Development